Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2017
89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid TumorsFrederike Bensch, Laetitia E Lamberts, Michaël M Smeenk, et al.
Lancet (London, England)|August 3, 2024
Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 studyAlwin Krämer, Tilmann Bochtler, Chantal Pauli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2015
First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid TumorsDidier Meulendijks, Wolfgang Jacob, Maria Martinez-Garcia, et al.
Cancer Cell|October 27, 2023
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancersEvelyn Jiagge, Dexter X Jin, Justin Y Newberg, et al.
European Urology Open Science|November 29, 2024
AGREE II Quality Assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by the OPTIMA ConsortiumVasileios Sakalis, Yagnaseni Bhattacharya, Katharina Beyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2017
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical ActivityDidier Meulendijks, Wolfgang Jacob, Emile E Voest, et al.
Pageof 3